Logo image of CSL

CARLISLE COS INC (CSL) Stock Fundamental Analysis

NYSE:CSL - New York Stock Exchange, Inc. - US1423391002 - Common Stock - Currency: USD

353.27  +5.04 (+1.45%)

After market: 353.27 0 (0%)

Fundamental Rating

7

CSL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. CSL gets an excellent profitability rating and is at the same time showing great financial health properties. CSL is not valued too expensively and it also shows a decent growth rate. With these ratings, CSL could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CSL had positive earnings in the past year.
CSL had a positive operating cash flow in the past year.
CSL had positive earnings in each of the past 5 years.
Each year in the past 5 years CSL had a positive operating cash flow.
CSL Yearly Net Income VS EBIT VS OCF VS FCFCSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

With an excellent Return On Assets value of 22.51%, CSL belongs to the best of the industry, outperforming 97.56% of the companies in the same industry.
Looking at the Return On Equity, with a value of 53.15%, CSL belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
CSL has a better Return On Invested Capital (17.21%) than 82.93% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CSL is above the industry average of 12.93%.
The last Return On Invested Capital (17.21%) for CSL is above the 3 year average (15.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 22.51%
ROE 53.15%
ROIC 17.22%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
CSL Yearly ROA, ROE, ROICCSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CSL has a better Profit Margin (26.17%) than 100.00% of its industry peers.
CSL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 22.85%, CSL belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
CSL's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 37.73%, CSL is doing good in the industry, outperforming 65.85% of the companies in the same industry.
CSL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.85%
PM (TTM) 26.17%
GM 37.73%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
CSL Yearly Profit, Operating, Gross MarginsCSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CSL is creating some value.
Compared to 1 year ago, CSL has less shares outstanding
Compared to 5 years ago, CSL has less shares outstanding
CSL has a better debt/assets ratio than last year.
CSL Yearly Shares OutstandingCSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSL Yearly Total Debt VS Total AssetsCSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 6.19 indicates that CSL is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 6.19, CSL is doing good in the industry, outperforming 73.17% of the companies in the same industry.
CSL has a debt to FCF ratio of 2.06. This is a good value and a sign of high solvency as CSL would need 2.06 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.06, CSL is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
CSL has a Debt/Equity ratio of 0.77. This is a neutral value indicating CSL is somewhat dependend on debt financing.
CSL has a worse Debt to Equity ratio (0.77) than 60.98% of its industry peers.
Even though the debt/equity ratio score it not favorable for CSL, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 2.06
Altman-Z 6.19
ROIC/WACC1.71
WACC10.04%
CSL Yearly LT Debt VS Equity VS FCFCSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CSL has a Current Ratio of 2.89. This indicates that CSL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.89, CSL is doing good in the industry, outperforming 75.61% of the companies in the same industry.
A Quick Ratio of 2.18 indicates that CSL has no problem at all paying its short term obligations.
CSL has a Quick ratio of 2.18. This is amongst the best in the industry. CSL outperforms 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 2.18
CSL Yearly Current Assets VS Current LiabilitesCSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

CSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.75%, which is quite impressive.
CSL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.74% yearly.
Looking at the last year, CSL shows a very negative growth in Revenue. The Revenue has decreased by -12.11% in the last year.
CSL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.79% yearly.
EPS 1Y (TTM)21.75%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%7.19%
Revenue 1Y (TTM)-12.11%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.41%

3.2 Future

The Earnings Per Share is expected to grow by 12.26% on average over the next years. This is quite good.
CSL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y11.81%
EPS Next 2Y12.1%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue Next Year4.21%
Revenue Next 2Y4.64%
Revenue Next 3Y5.06%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSL Yearly Revenue VS EstimatesCSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CSL Yearly EPS VS EstimatesCSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.48, the valuation of CSL can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CSL is on the same level as its industry peers.
CSL is valuated rather cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.63, the valuation of CSL can be described as correct.
Based on the Price/Forward Earnings ratio, CSL is valued a bit cheaper than 60.98% of the companies in the same industry.
CSL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.08.
Industry RankSector Rank
PE 17.48
Fwd PE 15.63
CSL Price Earnings VS Forward Price EarningsCSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CSL's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CSL is valued a bit cheaper than the industry average as 60.98% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.01
EV/EBITDA 12.72
CSL Per share dataCSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CSL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CSL may justify a higher PE ratio.
CSL's earnings are expected to grow with 12.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.48
PEG (5Y)0.89
EPS Next 2Y12.1%
EPS Next 3Y12.26%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.19%, CSL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.28, CSL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.57, CSL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.19%

5.2 History

On average, the dividend of CSL grows each year by 15.64%, which is quite nice.
CSL has paid a dividend for at least 10 years, which is a reliable track record.
CSL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.64%
Div Incr Years34
Div Non Decr Years34
CSL Yearly Dividends per shareCSL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

13.17% of the earnings are spent on dividend by CSL. This is a low number and sustainable payout ratio.
CSL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP13.17%
EPS Next 2Y12.1%
EPS Next 3Y12.26%
CSL Yearly Income VS Free CF VS DividendCSL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CSL Dividend Payout.CSL Dividend Payout, showing the Payout Ratio.CSL Dividend Payout.PayoutRetained Earnings

CARLISLE COS INC

NYSE:CSL (4/17/2025, 8:11:04 PM)

After market: 353.27 0 (0%)

353.27

+5.04 (+1.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners92.38%
Inst Owner Change0.05%
Ins Owners0.84%
Ins Owner Change2.05%
Market Cap15.60B
Analysts78.33
Price Target459 (29.93%)
Short Float %2.96%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 1.19%
Yearly Dividend3.74
Dividend Growth(5Y)15.64%
DP13.17%
Div Incr Years34
Div Non Decr Years34
Ex-Date02-18 2025-02-18 (1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.76%
Min EPS beat(2)-1.66%
Max EPS beat(2)0.14%
EPS beat(4)3
Avg EPS beat(4)8.17%
Min EPS beat(4)-1.66%
Max EPS beat(4)30.62%
EPS beat(8)6
Avg EPS beat(8)7.39%
EPS beat(12)10
Avg EPS beat(12)12.38%
EPS beat(16)14
Avg EPS beat(16)17.27%
Revenue beat(2)0
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)9%
Revenue beat(8)2
Avg Revenue beat(8)-0.76%
Revenue beat(12)4
Avg Revenue beat(12)0.94%
Revenue beat(16)8
Avg Revenue beat(16)1.6%
PT rev (1m)-0.37%
PT rev (3m)-3.44%
EPS NQ rev (1m)-0.86%
EPS NQ rev (3m)-17.27%
EPS NY rev (1m)-0.14%
EPS NY rev (3m)-1.76%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-5%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.95%
Valuation
Industry RankSector Rank
PE 17.48
Fwd PE 15.63
P/S 3.12
P/FCF 17.01
P/OCF 15.14
P/B 6.33
P/tB N/A
EV/EBITDA 12.72
EPS(TTM)20.21
EY5.72%
EPS(NY)22.6
Fwd EY6.4%
FCF(TTM)20.77
FCFY5.88%
OCF(TTM)23.34
OCFY6.61%
SpS113.33
BVpS55.79
TBVpS-11.77
PEG (NY)1.48
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 22.51%
ROE 53.15%
ROCE 22.19%
ROIC 17.22%
ROICexc 20.16%
ROICexgc 62.69%
OM 22.85%
PM (TTM) 26.17%
GM 37.73%
FCFM 18.33%
ROA(3y)15.61%
ROA(5y)11.62%
ROE(3y)36.9%
ROE(5y)27.85%
ROIC(3y)15.62%
ROIC(5y)12.39%
ROICexc(3y)17.52%
ROICexc(5y)13.93%
ROICexgc(3y)50.21%
ROICexgc(5y)41.16%
ROCE(3y)20.13%
ROCE(5y)15.97%
ROICexcg growth 3Y28.32%
ROICexcg growth 5Y11.4%
ROICexc growth 3Y36.27%
ROICexc growth 5Y11.03%
OM growth 3Y14.04%
OM growth 5Y10.94%
PM growth 3Y33.65%
PM growth 5Y21.71%
GM growth 3Y9.73%
GM growth 5Y5.76%
F-Score7
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 2.06
Debt/EBITDA 1.43
Cap/Depr 65.64%
Cap/Sales 2.26%
Interest Coverage 16.28
Cash Conversion 78.31%
Profit Quality 70.04%
Current Ratio 2.89
Quick Ratio 2.18
Altman-Z 6.19
F-Score7
WACC10.04%
ROIC/WACC1.71
Cap/Depr(3y)69.38%
Cap/Depr(5y)62.06%
Cap/Sales(3y)2.91%
Cap/Sales(5y)2.9%
Profit Quality(3y)99.02%
Profit Quality(5y)110.75%
High Growth Momentum
Growth
EPS 1Y (TTM)21.75%
EPS 3Y28.43%
EPS 5Y19.74%
EPS Q2Q%7.19%
EPS Next Y11.81%
EPS Next 2Y12.1%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.11%
Revenue growth 3Y9.26%
Revenue growth 5Y0.79%
Sales Q2Q%-0.41%
Revenue Next Year4.21%
Revenue Next 2Y4.64%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
EBIT growth 1Y2.61%
EBIT growth 3Y24.59%
EBIT growth 5Y11.81%
EBIT Next Year21.41%
EBIT Next 3Y12.82%
EBIT Next 5YN/A
FCF growth 1Y-13.42%
FCF growth 3Y47.3%
FCF growth 5Y8.35%
OCF growth 1Y-14.23%
OCF growth 3Y34.69%
OCF growth 5Y7.94%